Key result
Non-contrast CMR matches TEE with ~96% diagnostic accuracy for embolic sources.
Why the study?
Despite work-up with gold-standard transesophageal echocardiography, 20%-30% of strokes remain cryptogenic, prompting evaluation of noncontrast cardiovascular MRI to detect cardiac or aortic sources of emboli.
Does non-contrast cardiovascular MRI accurately detect cardiac and aortic sources of emboli compared to transesophageal echocardiogram in patients with cryptogenic ischemic stroke?
Cross-Sectional (n=24)
Double-blinded interpretation
No
Does non-contrast cardiovascular MRI accurately detect cardiac and aortic sources of emboli compared to transesophageal echocardiogram in patients with cryptogenic ischemic stroke?
Non-contrast cardiovascular MRI provides a highly accurate, non-invasive alternative to transesophageal echocardiography for detecting major cardiac sources of emboli in cryptogenic stroke patients.
Supports non-contrast CMRI as potential non-invasive option in cryptogenic stroke; leaves open prospective validation before clinical adoption.
OBJECTIVES: Despite a thorough work-up including transesophageal echocardiography, 20%-30% of stroke etiology remains cryptogenic. Transesophageal echocardiogram is considered the gold standard procedure to detect cardiac or aortic sources of emboli. In the recent years, cardiovascular MRI has emerged as a noninvasive, sound, and reliable modality to image morphological and functional abnormalities. In this study, we compared none contrast cardiovascular MRI to transesophageal echocardiogram, in the ability to detect cardiovascular source of embolus in cryptogenic ischemic strokes. METHODS: A series of 24 patients who were labeled, after a thorough stroke work-up, as having cryptogenic stroke, were examined with both transesophageal echocardiogram and noncontrast cardiovascular MRI to assess for cardiac or aortic source of emboli. The cardiologist who interpreted the transesophageal echocardiograms was blinded to the results of cardiovascular MRI. At the same time, the radiologist who interpreted the cardiovascular MRI was also blinded to the results of transesophageal echocardiogram. The cardiac lesions, with potential source of emboli that were assessed in our study included left ventricular thrombus, atrial septal aneurysm, and aortic atherosclerotic disease. The ability of cardiovascular MRI to identify potential source of cardiac embolus was then compared to that of transesophageal echocardiogram. RESULTS: Transesophageal echocardiogram detected ascending or arch aortic atherosclerotic plaque in 14 of the 24 patients. Other abnormalities detected include two atrial septal aneurysms and two left ventricular thrombus. Cardiovascular MRI was able to identify aortic atheroma in 13 patients; as well as three atrial septal aneurysms and two left ventricular thrombus. The accuracy of cardiovascular MRI to detect aortic atheroma, atrial septal aneurysm or left ventricular thrombus was great; 96%, 95.83%, and 100%, respectively. CONCLUSION: This small study suggests that, in patients with cryptogenic stroke, cardiovascular MRI is comparable to transesophageal echocardiogram in detecting cardiac and aortic source of emboli.
No takes yet. Share an insight, caveat, or question.
Mohammad et al. (2020) conducted a cross-sectional in Cryptogenic ischemic stroke (n=24). Non-contrast cardiovascular MRI vs. Transesophageal echocardiogram (TEE) was evaluated on Diagnostic accuracy of cardiovascular MRI for detecting aortic atheroma, atrial septal aneurysm, and left ventricular thrombus. Non-contrast cardiovascular MRI showed high diagnostic accuracy compared to transesophageal echocardiogram in detecting aortic atheroma (96%), atrial septal aneurysm (96%), and LV thrombus (100%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: